{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:45:31Z","timestamp":1793357131812,"version":"4.5.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The many comorbidities in the severely ill patient also make thrombocytopenia very common (\u223c 40%) in intensive care unit patients. The risk of bleeding is high with severe thrombocytopenia and is enhanced in intensive care patients with mild or moderately low platelet counts when additional factors are present that interfere with normal hemostatic mechanisms (eg, platelet function defects, hyperfibrinolysis, invasive procedures, or catheters). Even if not associated with bleeding, low platelet counts often influence patient management and may prompt physicians to withhold or delay necessary invasive interventions, reduce the intensity of anticoagulation, order prophylactic platelet transfusion, or change anticoagulants due to fear of heparin-induced thrombocytopenia. One approach to identify potential causes of thrombocytopenia that require specific interventions is to consider the dynamics of platelet count changes. The relative decrease in platelet counts within the first 3 to 4 days after major surgery is informative about the magnitude of the trauma or blood loss, whereas the dynamic of the platelet count course thereafter shows whether or not the physiologic compensatory mechanisms are working. A slow and gradual fall in platelet counts developing over 5 to 7 days is more likely to be caused by consumptive coagulopathy or bone marrow failure, whereas any abrupt decrease (within 1\u20132 days) in platelet counts manifesting after an initial increase in platelet counts approximately 1 to 2 weeks after surgery strongly suggests immunologic causes, including heparin-induced thrombocytopenia, other drug-induced immune thrombocytopenia, and posttransfusion purpura.<\/jats:p>","DOI":"10.1182\/asheducation-2010.1.135","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T19:08:48Z","timestamp":1295204928000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":149,"title":["Thrombocytopenia in the Intensive Care Unit Patient"],"prefix":"10.1182","volume":"2010","author":[{"given":"Andreas","family":"Greinacher","sequence":"first","affiliation":[{"name":"Institut f\u00fcr Immunologie und Transfusionsmedizin, Universit\u00e4tsklinikum, Ernst-Moritz-Arndt Universit\u00e4t Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Selleng","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Immunologie und Transfusionsmedizin, Universit\u00e4tsklinikum, Ernst-Moritz-Arndt Universit\u00e4t Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111708564027600_B1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/ajrccm.162.2.ncc3-00","article-title":"Thrombocytopenic disorders in critically ill patients","volume":"162","author":"Drews","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2019111708564027600_B2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0272-5231(03)00100-X","article-title":"Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients","volume":"24","author":"Drews","year":"2003","journal-title":"Clin Chest Med"},{"key":"2019111708564027600_B3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00003246-200006000-00031","article-title":"Thrombocytopenia and prognosis in intensive care","volume":"28","author":"Vanderschueren","year":"2000","journal-title":"Crit Care Med"},{"key":"2019111708564027600_B4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/00003246-200208000-00015","article-title":"Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome","volume":"30","author":"Strauss","year":"2002","journal-title":"Crit Care Med"},{"key":"2019111708564027600_B5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00003246-200204000-00005","article-title":"Time course of platelet counts in critically ill patients","volume":"30","author":"Akca","year":"2002","journal-title":"Crit Care Med"},{"key":"2019111708564027600_B6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.115.5.1363","article-title":"Thrombocytopenia in a surgical ICU","volume":"115","author":"Stephan","year":"1999","journal-title":"Chest"},{"key":"2019111708564027600_B7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jinf.2007.01.011","article-title":"Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia","volume":"55","author":"Brogly","year":"2007","journal-title":"J Infect"},{"key":"2019111708564027600_B8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1378\/chest.104.4.1243","article-title":"Thrombocytopenia in the intensive care unit","volume":"104","author":"Baughman","year":"1993","journal-title":"Chest"},{"key":"2019111708564027600_B9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hrtlng.2009.07.005","article-title":"Thrombocytopenia and outcome in critically ill patients with bloodstream infection","volume":"39","author":"Vandijck","year":"2010","journal-title":"Heart Lung"},{"key":"2019111708564027600_B10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcrc.2005.09.008","article-title":"Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors","volume":"20","author":"Crowther","year":"2005","journal-title":"J Crit Care"},{"key":"2019111708564027600_B11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/9781420016840-56","article-title":"Thrombocytopenia and Thrombocytosis","volume-title":"Trauma: Critical Care","author":"Arnold","year":"2007"},{"key":"2019111708564027600_B12","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1097\/00003246-200012000-00017","article-title":"Blunted rise in platelet count in critically ill patients is associated with worse outcome","volume":"28","author":"Nijsten","year":"2000","journal-title":"Crit Care Med"},{"key":"2019111708564027600_B13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1538-7836.2009.03626.x","article-title":"Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive","volume":"8","author":"Selleng","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2019111708564027600_B14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"2019111708564027600_B15","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"2019111708564027600_B16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/asheducation-2009.1.147","article-title":"Determinants of platelet number and regulation of thrombopoiesis","author":"Kaushansky","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2019111708564027600_B17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clpt.2004.08.010","article-title":"Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand","volume":"76","author":"Wang","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"2019111708564027600_B18","first-page":"362","article-title":"Cross-sectional guidelines for therapy with blood components and plasma derivatives: platelet concentrates","volume":"36","author":"The Board of the German Medical Association on the Recommendation of the Scientific Advisory Board","year":"2009","journal-title":"Transfus Med Hemother"},{"key":"2019111708564027600_B19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1537-2995.2001.41080977.x","article-title":"Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss","volume":"41","author":"Valeri","year":"2001","journal-title":"Transfusion"},{"key":"2019111708564027600_B20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"CRASH-2 Trial Collaborators","year":"2010","journal-title":"Lancet"},{"key":"2019111708564027600_B21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood.V56.1.88.bloodjournal56188","article-title":"Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation","volume":"56","author":"Neame","year":"1980","journal-title":"Blood"},{"key":"2019111708564027600_B22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1092871","article-title":"Thrombocytopenia in critically ill patients","volume":"34","author":"Levi","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"2019111708564027600_B23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"key":"2019111708564027600_B24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0002-9629(15)41648-9","article-title":"Review: postoperative thrombocytopenia: with etiologic, diagnostic, and therapeutic consideration","volume":"311","author":"Chang","year":"1996","journal-title":"Am J Med Sci"},{"key":"2019111708564027600_B25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000441-200102000-00003","article-title":"Acute respiratory distress syndrome as a major clinical manifestation of thrombotic thrombocytopenic purpura","volume":"321","author":"Chang","year":"2001","journal-title":"Am J Med Sci"},{"key":"2019111708564027600_B26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrc.2009.12.006","article-title":"The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients","volume":"25","author":"Crowther","year":"2010","journal-title":"J Crit Care"},{"key":"2019111708564027600_B27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1538-7836.2007.02870.x","article-title":"Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass","volume":"6","author":"Selleng","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2019111708564027600_B28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0049-3848(00)00311-X","article-title":"Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia. Report of four cases and review of literature","volume":"100","author":"Lubenow","year":"2000","journal-title":"Thromb Res"},{"key":"2019111708564027600_B29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0268-960X(89)90002-7","article-title":"Post-transfusion purpura","volume":"3","author":"Waters","year":"1989","journal-title":"Blood Rev"},{"key":"2019111708564027600_B30","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood.V79.9.2480.2480","article-title":"Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia\/IIa alloantibody (anti-HPA-5b)","volume":"79","author":"Warkentin","year":"1992","journal-title":"Blood"},{"key":"2019111708564027600_B31","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.127.2_suppl.53S","article-title":"Immune thrombocytopenia caused by glycoprotein IIb\/IIIa inhibitors","volume":"127","author":"Aster","year":"2005","journal-title":"Chest"},{"key":"2019111708564027600_B32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1538-7836.2006.01829.x","article-title":"Thrombocytopenia associated with the use of GPIIb\/IIIa inhibitors: position paper of the ISTH Working Group on Thrombocytopenia and GPIIb\/IIIa Inhibitors","volume":"4","author":"Aster","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2019111708564027600_B33","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2009-02-203034","article-title":"Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia","volume":"114","author":"Greinacher","year":"2009","journal-title":"Blood"},{"key":"2019111708564027600_B34","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ki.2008.609","article-title":"The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (experience of the Oklahoma TTP-HUS Registry, 1989\u20132007)","author":"George","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"2019111708564027600_B35","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1038\/ki.2008.622","article-title":"The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989\u20132007","author":"George","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"2019111708564027600_B36","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/01.CCM.0000259538.02375.A5","article-title":"Heparin-induced thrombocytopenia in intensive care patients","volume":"35","author":"Selleng","year":"2007","journal-title":"Crit Care Med"},{"key":"2019111708564027600_B37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"355","author":"Arepally","year":"2006","journal-title":"N Engl J Med"},{"key":"2019111708564027600_B38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1537-2995.2006.00892.x","article-title":"Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses","volume":"46","author":"Arnold","year":"2006","journal-title":"Transfusion"},{"key":"2019111708564027600_B39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-3476(86)81059-9","article-title":"Frequency and mechanism of neonatal thrombocytopenia","volume":"108","author":"Castle","year":"1986","journal-title":"J Pediatr"},{"key":"2019111708564027600_B40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1592\/phco.22.11.803.33634","article-title":"Risk markers for thrombocytopenia in critically ill patients: a prospective analysis","volume":"22","author":"Shalansky","year":"2002","journal-title":"Pharmacotherapy"},{"key":"2019111708564027600_B41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/106002809703100302","article-title":"Incidence and risk factors of thrombocytopenia in critically ill trauma patients","volume":"31","author":"Hanes","year":"1997","journal-title":"Ann Pharmacother"},{"key":"2019111708564027600_B42","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/0310057X0703500604","article-title":"Thrombocytopenia in septic shock patients\u2013a prospective observational study of incidence, risk factors and correlation with clinical outcome","volume":"35","author":"Sharma","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"2019111708564027600_B43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2141.1996.5101050.x","article-title":"The incidence and cause of coagulopathies in an intensive care population","volume":"93","author":"Chakraverty","year":"1996","journal-title":"Br J Haematol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/135\/1493917\/bep00110000135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/135\/1493917\/bep00110000135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T13:56:51Z","timestamp":1573999011000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2010\/1\/135\/96088\/Thrombocytopenia-in-the-Intensive-Care-Unit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,4]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12,4]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2010.1.135","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,4]]}}}